The chart below shows how HCA performed 10 days before and after its earnings report, based on data from the past quarters. Typically, HCA sees a +1.22% change in stock price 10 days leading up to the earnings, and a +2.04% change 10 days following the report. On the earnings day itself, the stock moves by -1.38%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Earnings Per Share Increase: Diluted earnings per share as adjusted increased 5.4% in the 4th quarter compared to the prior year, despite the financial impact of hurricanes estimated at approximately $0.60 per share.
Strong Revenue Demand: Revenue growth was approximately 6%, with same facility net revenue per equivalent admissions increasing 2.9% over the prior year, indicating strong demand and payer mix.
Adjusted EBITDA Growth: For the full year 2024, adjusted EBITDA increased by 9% over the prior year, reflecting solid operational performance despite challenges from hurricanes.
Operational Cash Flow Increase: Cash flow from operations was $10.5 billion for the year, representing an 11% increase over the prior year, showcasing strong financial health and operational efficiency.
Share Repurchase and Dividend Increase: The Board of Directors authorized a new $10 billion share repurchase program and increased the quarterly dividend from $0.66 to $0.72 per share, reflecting confidence in the company's financial position.
Negative
EBITDA Margin Decline: Adjusted EBITDA margin declined by 60 basis points compared to the prior year quarter, primarily due to the impact of hurricanes, which had a 100 basis point unfavorable impact on adjusted EBITDA margin.
Hurricane Financial Impact: The estimated financial impact from hurricanes in Q4 was approximately $200 million, equating to a loss of $0.60 per diluted share, which negatively affected overall earnings.
Hurricane Impact on Earnings: Full year 2024 results were adversely impacted by hurricanes, with an estimated total impact of $250 million or $0.73 per diluted share, indicating significant losses due to natural disasters.
Respiratory Season Impact: The 4th quarter saw a depressed respiratory season, which contributed to a 1-point drag on same facility admission growth and a 2-point drag on emergency room visits compared to the prior year.
Medicaid Reimbursement Challenges: The guidance for 2025 anticipates a potential $250 million headwind from Medicaid supplemental payment programs, reflecting a challenging outlook for reimbursement in the upcoming year.
Earnings call transcript: HCA Holdings beats Q4 2024 EPS forecast but stock dips
HCA.N
6.07%